Header cover image

Singaporean Pharmaceuticals & Biotech Breakout Stocks

Results

1

1 new

Stocks where the price continues to rise after more than a year of consistent gains.

1 companies

iX Biopharma

Market Cap: S$462.9m

A specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, the United States, China, and Australia.

New

42C

S$0.52

7D

24.1%

1Y

2,352.4%